Management of Breakthrough Seizure in Patients with Epilepsy

Immediate Management: Phenobarbital Loading

The American College of Emergency Physicians suggests that phenobarbital is equally efficacious as lorazepam, phenytoin, and phenytoin plus diazepam for seizure control, making it appropriate as monotherapy when optimized, with a recommended loading dose of 10-20 mg/kg to rapidly achieve therapeutic levels 1, 2
The seizure recurrence rate in patients with epilepsy presenting after breakthrough seizures is approximately 8-11%, but this risk is directly related to inadequate antiepileptic drug levels, highlighting the importance of optimizing phenobarbital levels 1, 2

A non-focal neurological examination in a patient with known seizure disorder and documented subtherapeutic antiepileptic drug levels makes breakthrough seizure the most likely diagnosis, and emergency medicine guidelines indicate that neuroimaging is low yield in such cases 3
Defer CT/MRI unless new focal neurological deficits develop, persistent altered mental status after achieving therapeutic phenobarbital levels, history of head trauma, or failure to respond to appropriate antiepileptic drug loading, as recommended by emergency medicine guidelines 3

Respiratory depression and hypotension are the primary concerns with phenobarbital loading, but these are manageable with appropriate monitoring and occur less frequently than commonly feared, with serious adverse events occurring in only a small percentage of patients 1, 4